Florida Senate - 2022                          SENATOR AMENDMENT
       Bill No. CS for SB 544
       
       
       
       
       
       
                                Ì703254ÉÎ703254                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                                       .                                
                                       .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       Senator Pizzo moved the following:
       
    1         Senate Amendment (with title amendment)
    2  
    3         Between lines 107 and 108
    4  insert:
    5         Section 4. Paragraph (o) is added to subsection (3) of
    6  section 1002.20, Florida Statutes, to read:
    7         1002.20 K-12 student and parent rights.—Parents of public
    8  school students must receive accurate and timely information
    9  regarding their child’s academic progress and must be informed
   10  of ways they can help their child to succeed in school. K-12
   11  students and their parents are afforded numerous statutory
   12  rights including, but not limited to, the following:
   13         (3) HEALTH ISSUES.—
   14         (o) Naloxone use and supply.—
   15         1. A public school may purchase a supply of the opioid
   16  antagonist naloxone from a wholesale distributor as defined in
   17  s. 499.003 or may enter into an arrangement with a wholesale
   18  distributor or manufacturer as defined in s. 499.003 for
   19  naloxone at fair-market, free, or reduced prices for use in the
   20  event that a student has an opioid overdose. The naloxone must
   21  be maintained in a secure location on the public school’s
   22  premises. The participating school district shall adopt a
   23  protocol developed by a licensed physician for the
   24  administration of the drug by school personnel trained to
   25  recognize an opioid overdose and to administer naloxone.
   26         2. The school district and its employees and agents and the
   27  physician who provides the standing protocol for school naloxone
   28  are not liable for any injury arising from the use of the drug
   29  if it is administered by trained school personnel who follow the
   30  standing protocol and whose professional opinion is that the
   31  student is having an opioid overdose:
   32         a. Unless the trained school personnel’s action is willful
   33  and wanton;
   34         b. Notwithstanding that the parents or guardians of the
   35  student to whom the naloxone is administered have not been
   36  provided notice or have not signed a statement acknowledging
   37  that the school district is not liable; and
   38         c. Regardless of whether authorization has been given by
   39  the student’s parents or guardians or by the student’s
   40  physician, physician’s assistant, or advanced practice
   41  registered nurse.
   42  
   43  ================= T I T L E  A M E N D M E N T ================
   44  And the title is amended as follows:
   45         Delete line 24
   46  and insert:
   47         specified timeframe; amending s. 1002.20, F.S.;
   48         authorizing a public school to purchase or enter into
   49         an arrangement to receive a supply of the opioid
   50         antagonist naloxone for a certain purpose; specifying
   51         requirements for the maintenance of the naloxone;
   52         requiring the school district to adopt a protocol for
   53         the administration of naloxone; providing that a
   54         school district and its employees and agents and the
   55         physician who provides the protocol are not liable for
   56         any injury arising from the administration of the
   57         naloxone pursuant to the protocol; providing an
   58         exception; providing an effective date.